Claus, I. et al. 2025. Metabolomics for Distinguishing Cardiovascular Risk in Rheumatoid Arthritis Across Different Disease-Modifying Antirheumatic Drug Therapies. Journal of Clinical Medicine Research. 17, 2 (Feb. 2025), 89–96. DOI:https://doi.org/10.14740/jocmr6145.